Izotropic Corporation (CSE:IZO)
Canada · Delayed Price · Currency is CAD 0.2250
+0.0350 (18.42%)
Sep 18, 2026, 9:30 AM EST
Izotropic Company Description
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers.
It develops and commercializes IzoView, a breast CT imaging system. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
Izotropic Corporation
| Country | Canada |
| Founded | 2016 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Robert Thast |
Contact Details
Address: 800-15355 24th Avenue Surrey, BC V4A 2H9 Canada | |
| Phone | 833-496-2677 |
| Website | izocorp.com |
Stock Details
| Ticker Symbol | IZO |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| ISIN Number | CA46604F1099 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Robert Louis Thast | Founder, Interim Chief Executive Officer and Chairman |
| Ralph F. Proceviat CPA | Chief Financial Officer and Director |
| Dr. Younes Achkire Ph.D. | Executive Vice President of Product Engineering and Chief Operating Officer |
| Ali Reza Sodagar | Legal Advisor and Independent Director |
| Dr. Andrew M. Hernandez | Head of Imaging Technology |
| Jaclyn Thast | Operations Manager and Corporate Secretary |